Menu
/REGISTER
Montecito
Nixon Peabody
Pac Premier
Loading...
You are here:  Home  >  'Otezla'
Latest

Amgen’s Otezla could be treatment for COVID-19

By   /  Friday, May 8th, 2020  /  Biotech, Central Coast Health Watch, Earnings, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen’s Otezla could be treatment for COVID-19

Amgen’s newly acquired Otezla product line could find a role in a suite of new therapies designed to treat COVID-19 patients. News of the potential for the rheumatoid arthritis product came as the Thousand Oaks-based biotech reported that earnings and revenue shot up in the first quarter. The company’s outlook stayed flat as it shifts Read More →

Read More →
Latest

Amgen releases 4th quarter earnings

By   /  Thursday, January 30th, 2020  /  Biotech, Earnings, Latest news  /  Comments Off on Amgen releases 4th quarter earnings

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Arcutis planning $152 million IPO

By   /  Tuesday, January 28th, 2020  /  Biotech, Latest news  /  Comments Off on Arcutis planning $152 million IPO

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Biotech giant Amgen bails on brain research

By   /  Friday, November 1st, 2019  /  Biotech, Earnings, East Ventura County, Top Stories, Top Story, Tri-County Public Companies  /  Comments Off on Biotech giant Amgen bails on brain research

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen trades cash for cash flow with Otezla deal

By   /  Friday, August 30th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Top Stories, Top Story, Tri-County Public Companies  /  Comments Off on Amgen trades cash for cash flow with Otezla deal

Amgen’s $13.4 billion acquisition of lucrative psoriasis therapy Otezla secures nearly a decade of revenue growth for the biotech giant to bridge the gap between its waning legacy products and potential new contenders. The relatively small deal could nonetheless change the landscape of the biotech industry, allowing regulators to approve a $74 billion takeover bid Read More →

Read More →
Latest

Dubroff: 5 reasons to pay attention to Amgen’s Otezla deal

By   /  Friday, August 30th, 2019  /  Biotech, Columns, Latest news  /  Comments Off on Dubroff: 5 reasons to pay attention to Amgen’s Otezla deal

Henry Dubroff

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →